Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register

COVID-19 infection causes respiratory pathology with severe interstitial pneumonia and extra-pulmonary complications; in particular, it may predispose to thromboembolic disease. The current guidelines recommend the use of thromboprophylaxis in patients with COVID-19, however, the optimal heparin dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Poli, Daniela, Antonucci, Emilia, Ageno, Walter, Prandoni, Paolo, Palareti, Gualtiero, Marcucci, Rossella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Im - Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720160/
https://www.ncbi.nlm.nih.gov/pubmed/34973126
http://dx.doi.org/10.1007/s11739-021-02891-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720160/
https://www.ncbi.nlm.nih.gov/pubmed/34973126
http://dx.doi.org/10.1007/s11739-021-02891-w

Ejemplares similares